Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Perfusion Analysis Using Rubidium in Cardiac Sarcoidosis (PARCS)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier:
NCT01648933
First received: April 12, 2012
Last updated: June 23, 2016
Last verified: June 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2016
  Primary Completion Date: September 2015 (Final data collection date for primary outcome measure)